2024-516970-31-00CompletedPhase 2
Molecular imaging exploration of ocular angiogenic activity and evaluation of its value in therapeutic follow-up of AMD patients
Molecular imaging exploration of ocular angiogenic activity and evaluation of its value in therapeutic follow-up of AMD patients
Source: EU CTIS (euclinicaltrials.eu) · Last updated 17 Oct 2024
Brief summary (registry, in English)
Evaluate the ability of 68Ga-NODAGA-RGD PET imaging to demonstrate, in 20 patients with unilateral AMD, a molecular therapeutic response to intraocular antiangiogenic injections at the end of the induction phase (after 3 months of treatment).
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 27 Sept 2024
- Start date
- 2 Oct 2022
- Lead sponsor
- Centre Hospitalier Regional De Marseille
- Diseases
- Macular degeneration
- EU CT number
- 2024-516970-31-00
- EudraCT number
- 2019-000946-37
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 20
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients previously treated with antiangiogenic therapy.
Age
- Age ≤ 18 years
Other
- pregnant or breast-feeding women
- Patients with bilateral AMD
- Patients with AMD with no neovascularization focus as assessed by the standard diagnostic battery
- Patients suffering from any other ophthalmological pathology
- Monophtalmic patients
Who the study is looking for
- Age ≥ 18 years
- signed informed consent
- Patient with unilateral AMD, with at least 1 focus of choroidal neovascularization on OCT, naïve to any antiangiogenic treatment.
- Initial check-up including at least OCT and visual acuity measurement, maximum 1 month old at the time of the 68Ga-NODAGA-RGD PET scan
- affiliation to a social security scheme.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Regional De Marseille | Marseille | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.